Prohair

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prohair

Property Description
Active ingredient Finasteride
Form Oral Tablet (Film-coated)
Pharmacological class 5alpha-Reductase Inhibitor
Common use Management of androgen-dependent conditions
Origin Synthetic (4-azasteroid compound)

What is the Active Ingredient and Form of Prohair?

Prohair is a prescription-only medicine (-only) centered on the active ingredient finasteride, a highly potent synthetic substance that is chemically defined as a 4-azasteroid compound. This product is manufactured as an oral tablet for systemic action, typically appearing as a film-coated tablet intended for ingestion by adult males. Finasteride is the same core therapeutic agent found in other well-known brands such as Propecia and Proscar. Finasteride is available only with a doctor's prescription, which underscores its role as a controlled therapeutic agent requiring medical oversight.

Prohair’s Pharmacological Classification and Type

The medication is classified pharmacologically as a highly selective 5alpha-reductase inhibitor, a drug group clinically recognized for its reliable antiandrogenic effects. This precise classification is vital because the drug’s primary function is not general hormone blockade, but a highly targeted, enzymatic action. Finasteride acts as a competitive inhibitor, specifically demonstrating a potent preference for the Type II 5alpha-reductase isozyme over Type I. This established selectivity sets its mechanism apart within the class of 5alpha-reductase inhibitors.

Core Action and General Therapeutic Purpose

The fundamental action of the drug is the reduction of dihydrotestosterone (DHT) production by blocking the conversion of testosterone to DHT via the Type II enzyme. This targeted process is the foundation of its general therapeutic purpose. This mechanism is employed to manage conditions where DHT plays a clear, adverse role, such as the management of benign prostatic hyperplasia (BPH) and androgenetic alopecia in men. This established hormonal modulation helps to relieve or manage biological processes driven by elevated or highly active DHT levels.

Regulatory References

  1. MedlinePlus Drug Information
  2. StatPearls - NCBI Bookshelf

What side effects are possible with Prohair?

Possible Side Effects and Safety Information

The safety profile for Prohair (often referred to generically as finasteride) is primarily characterized by adverse reactions related to its hormonal mechanism, with officially documented events covering sexual, psychiatric, and dermatologic categories.

Common and Clinically Significant Adverse Reactions

The most commonly reported side effects, typically occurring in 1% to 10% of users, involve the reproductive system:

  • Sexual Dysfunction: Decreased libido (sex drive), erectile dysfunction (inability to get or maintain an erection), and ejaculation disorders, including a reduction in ejaculate volume.
  • Breast Disorders: Breast tenderness and enlargement (gynecomastia) have been reported.

Serious and Persistent Safety Concerns

Regulatory authorities globally (including the FDA and EMA) have noted post-marketing reports of serious adverse reactions, which include:

  • Psychiatric Effects: Depressed mood, clinical depression, and suicidal ideation have been documented as possible side effects. Users are advised to monitor for changes in mood.
  • Persistent Symptoms: A serious, clinically significant risk involves the persistence of sexual dysfunction (e.g., decreased libido, erectile dysfunction, ejaculation disorders) in a subset of men after treatment has been stopped.
  • Other Rare Events: Testicular pain, male infertility, and severe allergic reactions (e.g., swelling of the lips and face) have been reported.

Specific Safety Restrictions and Warnings

Prohair is contraindicated in pregnant women due to the potential risk of causing abnormalities of the external genitalia in a male fetus. For this reason, women who are or may become pregnant should not handle crushed or broken tablets, as the active ingredient can be absorbed through the skin. Furthermore, the drug may affect the results of the Prostate Specific Antigen (PSA) test used for prostate cancer screening; this interaction should be disclosed to all involved healthcare providers.

Overdose and Emergency Response

The official regulatory documentation for Prohair (finasteride) outlines the procedural requirements for managing a suspected overdose, rather than listing specific manifestations. Clinical experience with accidental overdose is limited, as stated in prescribing information. No specific signs or symptoms have been formally documented following clinical trials, including those involving single doses up to 400 mg or repeated daily doses up to 80 mg for three months. This absence of specified outcomes means that overdose is not associated with a predictable symptom profile.

When to Seek Immediate Medical Help

It is a regulatory mandate that immediate medical attention must be sought if an overdose of Prohair is suspected or known to have occurred. This action is required regardless of whether symptoms are present at the time of suspicion. Patients should contact a poison control center or hospital emergency department right away, as stated in government guidance.

Overdose Management

Due to the limited data on clinical manifestations, the primary approach is supportive care. No specific antidote is known to counteract the effects of a finasteride overdose, as officially stated in the labeling. Management therefore consists of providing generalized symptomatic and supportive treatment. The patient’s clinical status must be closely monitored by a healthcare professional, and hospital observation may be required depending on the clinical assessment.

Therapeutic Uses of Prohair

What Prohair Treats: Main Uses and Benefits


The therapeutic application of Prohair (finasteride) is primarily focused on two chronic, androgen-driven conditions in adult males. The medication is commonly used to provide symptomatic support across these two distinct domains.

Key Therapeutic Focus

Prohair is relevant for managing the progressive symptoms of benign prostatic hyperplasia (BPH) and for addressing androgenetic alopecia (AGA), also known as male pattern hair loss. This approach helps manage symptoms that interfere with daily functioning by easing the overall symptom load related to urological discomfort and gradual hair thinning. It is generally applied in contexts where patients experience mild to moderate manifestations of these conditions.

“The treatment is commonly used in conditions marked by increased physiological stress, focusing on symptomatic support.”


Symptom Domains and Benefits

In BPH, the medication generally helps to improve urine flow and contributes to easing the symptom load associated with a weak stream, incomplete emptying, and disruptive nocturia. Its long-term use may assist with managing the disease progression, which includes a role in reducing the risk of complications such as acute urinary retention. For AGA, it helps in the management of existing hair and may assist with promoting the growth of thicker hair, supporting patients in maintaining a sense of stability.

Quick Fact: Supportive Management for BPH Quick Fact: Supportive Management for AGA
Supports comfort by easing obstructive urinary symptoms and helping with the management of nighttime frequency. Contributes to improved comfort by managing further hair thinning and may assist with the growth of new, substantial hair.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The official regulatory profile for Prohair (finasteride) strictly limits its use to the adult male population. Eligibility is defined by absolute contraindications and specific population limitations documented in official government labeling.


Contraindications and Restrictions

Population Group Regulatory Status Constraint Context
Women Contraindicated Prohibited for use in females for any indication.
Pregnant Women Absolutely Contraindicated High risk of abnormal development of the external genitalia in a male fetus (teratogenicity).
Pediatric Patients Not Indicated/Not Established Safety and effectiveness have not been established in individuals under 18 years of age.
Hypersensitivity Contraindicated Known allergy to finasteride or any component of the tablet.

Eligibility Conditions

Finasteride use is authorized only for adult men (18 years and older).

  • Older Adults (Geriatric): Use is permitted with no dosage adjustment required, as the change in elimination rate in the elderly is not considered clinically significant.
  • Renal Impairment: No dosage adjustment is necessary in patients with any degree of chronic renal insufficiency.
  • Hepatic Impairment: Caution should be used in patients with liver function abnormalities, as the medicine is extensively metabolized in the liver. However, no specific dose adjustment is officially mandated.

Pregnant women must not handle crushed or broken Prohair tablets due to the risk of absorption.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information indicates that no drug interactions of clinical importance have been identified with Prohair based on studies with commonly used compounds. The product does not appear to significantly affect the cytochrome P450-linked drug metabolism enzyme system, which is responsible for processing many medications in the body.

Compounds that have been tested for potential interaction and found to have no clinically meaningful results include antipyrine, digoxin, propranolol, theophylline, and warfarin. Furthermore, it has been used concomitantly in studies with a variety of drug classes, such as acetaminophen, acetylsalicylic acid, beta blockers, calcium-channel blockers, and HMG-CoA reductase inhibitors, without evidence of clinically significant adverse interactions.

Procedural and Test Interference

The primary interaction-related requirement involves Prostate Specific Antigen (PSA) testing. Prohair causes a significant decrease in serum PSA levels. This effect must be accounted for when interpreting PSA results for prostate cancer screening. Any confirmed increase in a patient's PSA level from the lowest value observed while on Prohair therapy should be carefully evaluated, even if the value remains within the normal range for men not taking this product. This mandates an interpretive adjustment by healthcare providers for diagnostic test results.

Mechanism of Action

Selective Blockade of the 5alpha-Reductase Enzyme

The mechanism of Prohair involves a selective action that interrupts a core pathway in the body’s androgen metabolism, leading to physiological consequences in target tissues. Prohair is a competitive inhibitor that binds to the 5alpha-Reductase Type II isozyme , thereby blocking the conversion of the precursor hormone Testosterone into the potent androgen, Dihydrotestosterone (DHT).

Modulation of Androgenic Signaling and Tissue Influence

By interrupting this metabolic pathway, the mechanism results in a decrease in local and systemic DHT concentration. This reduction modulates the level of androgenic signals targeting sensitive tissues, influencing the physiological process of follicular miniaturization and the follicular growth cycle.

Mechanism-Dependent Onset and Constraint

The molecular action (enzyme inhibition) is rapid, but the resulting physiological consequence (follicular modulation) is inherently slow, tied to the multi-month duration of the hair cycle. The mechanism's activity is limited to biological processes driven by DHT and exhibits less potency against the 5alpha-reductase Type I isozyme.

Dosage and Administration Information

How to Use Prohair: Official Administration Guidelines

Prohair (finasteride) is prescribed for oral administration and is available as a film-coated tablet in two primary strengths: 1 mg and 5 mg. The administration regimen focuses on continuous, long-term daily use to maintain its systemic action.


Standard Dosage and Frequency

Usage is categorized by the condition being addressed, with a fixed, once-daily dose:

Condition Standard Labeled Dose Frequency
Androgenetic Alopecia (AGA) 1 mg Once daily
Benign Prostatic Hyperplasia (BPH) 5 mg Once daily

This medicine must be taken once daily (OD), regardless of the strength. The continuous daily schedule is a required usage pattern, as stopping administration typically results in a gradual reversal of its effects over time.


Procedural and Population Rules

For proper administration, the tablet should be swallowed whole and must not be crushed, broken, or divided. The timing of ingestion is flexible, as the tablet may be taken with or without food.

No dosage adjustment is required for older adults or for patients with renal impairment. If a dose is missed, the user should not take an extra tablet; the prescribed schedule should simply be resumed with the next planned dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Prohair

Evidence for Use in Benign Prostatic Hyperplasia (BPH)

The research base for finasteride's use in Benign Prostatic Hyperplasia (BPH) includes large-scale Randomized Controlled Trials (RCTs), alongside long-term observational extension studies. These investigations were used in research exploring how symptoms change over time. The populations evaluated were adult males, typically over the age of 50, diagnosed with symptomatic BPH. Studies monitored objective physical changes, such as the reduction in prostate volume and changes in maximum urinary flow rate (Qmax). Research described the patterns observed across the treatment and control groups and included the evaluation of BPH-related clinical events as a studied outcome.

What remains uncertain is the full picture of long-term outcomes beyond ten years, as follow-up durations were limited in the initial controlled trials. The evidence suggests a pattern where the measured outcomes were observed in relation to the patient's initial prostate size, indicating data for men with smaller prostates may be insufficient compared to those with significant enlargement.


Evidence for Use in Androgenetic Alopecia (AGA)

Research exploring Androgenetic Alopecia (AGA), or male pattern hair loss, includes placebo-controlled RCTs applied in studies examining patient-reported experiences. These trials primarily involved adult males aged 18 to 41 with mild to moderate hair thinning. Research examined outcomes related to hair count and appearance using methods like quantification of hair count and photographic assessments. Studies described that measured outcomes diminished or returned to baseline in subjects who discontinued the substance.

Evidence is limited for certain groups. The results apply primarily to the younger population studied; data for men outside this range or for those presenting with advanced stages of hair loss remain insufficient. Additionally, data describing the use or outcomes of this medicine in children or in female populations for these indications remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Prohair (FAQ)


Q: Is Prohair a steroid?

Prohair's active ingredient, finasteride, is chemically classified as a 4-azasteroid compound. This means it shares a structural similarity with certain steroids. However, it functions as a 5alpha-reductase inhibitor, not as an anabolic steroid used for muscle building.


Q: Does Prohair work on a receding hairline or only the crown?

Studies and official information indicate that Prohair can be effective in treating hair loss in men. While clinical trials have shown strong results for increasing hair growth and slowing loss on the crown (vertex), some data suggest it may help reduce hair loss across other areas of the scalp, potentially including the hairline, though evidence may be less extensive than for the crown.


Q: Can Prohair affect mood or cause depression?

Yes, official regulatory documents list psychiatric effects such as depressed mood, clinical depression, and even suicidal ideation as possible side effects reported during post-marketing surveillance. Individuals using this medicine should monitor for any changes in their mood.


Q: What age groups is Prohair most often used in?

Prohair is approved for use only in adult men (age 18 and older). While clinical trials for hair loss were primarily conducted in men aged 18 to 41, the medicine is also used to manage Benign Prostatic Hyperplasia (BPH) in older men, typically over the age of 50.


Q: Is it safe to take Prohair if I have liver problems?

Since Prohair is processed extensively by the liver, official information states that caution should be used in patients who have abnormal liver function. The decision to use this medicine requires consultation with a healthcare professional regarding liver function.


Q: How is Prohair eliminated from the body?

The active ingredient in Prohair is extensively metabolized (broken down) in the liver. The resulting inactive byproducts are then excreted from the body mainly through both the urine and the feces.


Q: Can I donate blood while I am taking Prohair?

Regulatory guidance often advises men to wait for a specific period, typically one month after taking the last dose of Prohair, before donating blood. This precaution is taken due to the potential risk the medicine poses if transferred to a woman who is pregnant.


Q: How quickly does Prohair start working for hair loss?

The mechanism of action for Prohair is tied to the multi-month duration of the hair growth cycle. Official clinical information suggests that it may take at least three months of continuous, daily use before patients notice any objective improvement in hair loss or new hair growth.


Q: Can Prohair cause weight gain?

In the main clinical studies, weight gain was not reported as a common side effect of Prohair. However, some less common or post-marketing reports have included mentions of 'unusual weight gain or loss.'


Q: Are the side effects of Prohair permanent if I stop taking it?

Official regulatory warnings note a serious, clinically significant risk where sexual dysfunction (such as decreased libido or erectile dysfunction) may persist in a subset of men even after they have completely stopped the treatment.


Q: Are there any documented long-term side effects from Prohair use?

Long-term studies and post-marketing reports have documented effects such as sexual side effects, breast disorders (including breast enlargement, or gynecomastia), and potential development of high-grade prostate cancer when the higher 5 mg dose is used.


Q: Are there generic versions of Prohair available?

Yes, finasteride, the active ingredient in Prohair, is widely available in generic form. Once patent protections expire for the branded product, generic versions are typically approved by regulatory bodies.


Q: What is the relationship between Prohair and hormones?

Prohair acts as a targeted inhibitor that impacts the hormone system. Its function is to block the enzyme 5alpha-Reductase Type II, which is responsible for converting the hormone testosterone into the more potent hormone, dihydrotestosterone (DHT).


Q: Why do some people report feeling light-headed on Prohair?

Feeling dizzy or light-headed when standing up (known as orthostatic hypotension) has been reported, particularly in men taking the higher dose for Benign Prostatic Hyperplasia (BPH) when it is used alongside certain other blood pressure medications (alpha-blockers).


Q: What are the signs that Prohair is not working for me?

Efficacy is measured by objective signs like an increase in hair count or photographic evidence of improvement. The absence of measured improvements, such as changes in hair count or photographic evidence, after the typical onset period may be discussed with a healthcare provider.


Q: Does the efficacy of Prohair vary greatly between individuals?

Data from clinical trials indicate that the individual response to Prohair can vary. Not all subjects experienced the same degree of measured improvement, suggesting the medicine is not equally effective for every user.


Q: Is the research evidence for Prohair conclusive?

The medicine’s approvals for both hair loss and BPH are supported by large-scale, placebo-controlled trials. However, regulatory documents specifically note that evidence is limited for certain groups, such as men with advanced stages of hair loss or for very long-term outcomes beyond ten years.


Q: Can Prohair affect hair thickness as well as growth?

Yes, official information indicates that Prohair can influence both hair growth and thickness. The medicine works by reversing the process of follicular miniaturization, which is what causes hair to become shorter and thinner over time.


Q: Are there any common reasons people stop taking Prohair?

Adverse events related to the reproductive system are the most frequently cited reasons for discontinuation in clinical trials. These include commonly reported side effects such as decreased libido, erectile dysfunction, and ejaculation disorders.


Q: Why is Prohair sometimes prescribed for conditions other than hair loss?

In addition to male pattern hair loss (Androgenetic Alopecia), Prohair is officially indicated and prescribed for the management of Benign Prostatic Hyperplasia (BPH), which is an enlargement of the prostate gland in men.


Q: Are there any major diet restrictions while taking Prohair?

No, official administration guidelines confirm that Prohair tablets may be taken with or without food, meaning there are no major dietary restrictions required to ensure proper absorption or efficacy.


Q: Is Prohair more effective the earlier you start using it?

Clinical trials for hair loss primarily enrolled and studied younger men (aged 18 to 41) who had mild to moderate hair thinning. This focus suggests that the medicine’s demonstrated efficacy is strongest when treatment is initiated in the earlier stages of the condition.

How should Prohair be stored and disposed of?

How to Store and Dispose of Prohair (Finasteride)

Finasteride tablets must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The medication must be kept in its original, tightly closed container and protected from light and excess moisture.

A crucial safety requirement is to store Prohair out of the reach of children.

Special Handling and Disposal

Pregnant women or women who may potentially be pregnant must not handle crushed or broken finasteride tablets, as the active ingredient can be absorbed through the skin. If contact occurs, the area should be washed immediately with soap and water.

Unused or expired product should be disposed of by following local regulatory requirements. This is often accomplished through a drug take-back program or, if unavailable, by following specific household trash disposal steps recommended by regulators, such as mixing the tablets with an undesirable substance before sealing and discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prohair found in:

A-Z Index: